Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

2.71
+0.07002.65%
Post-market: 2.710.00000.00%16:10 EST
Volume:19.84K
Turnover:54.07K
Market Cap:30.31M
PE:-1.55
High:2.79
Open:2.64
Low:2.61
Close:2.64
52wk High:5.74
52wk Low:2.53
Shares:11.18M
Float Shares:8.59M
Volume Ratio:0.32
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7524
EPS(LYR):-1.9309
ROE:-104.58%
ROA:-55.99%
PB:3.16
PE(LYR):-1.40

Loading ...

Company Profile

Company Name:
Lantern Pharma Inc.
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
24
Office Location:
1920 McKinney Avenue,7th Floor,Dallas,Texas,United States
Zip Code:
75201
Fax:
- -
Introduction:
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors. The company also develops LP-300 as a combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; and LP-284, a novel small molecule and DNA damaging agent for the treatment of mantle cell lymphoma and double hit lymphoma. In addition, it offers LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Directors

Name
Position
Donald Jeff Keyser
Chairman of the Board
Panna Sharma
Chief Executive Officer, President and Director
David S. Silberstein
Director
Lee T. Schalop
Director
Maria Maccecchini
Director
Vijay Chandru
Director

Shareholders

Name
Position
Panna Sharma
Chief Executive Officer, President and Director
David R. Margrave
Chief Financial Officer and Secretary
Kishor G. Bhatia
Chief Scientific Officer